Updates in Primary Care

Friday, March 20, 2026, 8:30 AM - 12:30 PM, online


In this course, general pediatric providers will learn about common general pediatric conditions and concerns including newborn genital anomalies, atopic dermatitis, allergies, and oral contraceptives. Experts will explore current guidelines and standards of care for each topic along with practice management pearls related to billing, time management, or referrals. In addition, we will explore hot topics as we look back on the top journal articles of the past year.

1. Identify neonatal genital anomalies and the timeline for intervention.
2. Differentiate topical steroids by potency and appropriate duration of use by body location for the treatment of atopic dermatitis.
3. Explore new treatment options to manage pediatric allergies.
4. Explore options for initiating oral contraceptives.
5. Determine appropriate and timely referrals to specialty care for a variety of common pediatric concerns and diagnoses, including hypospadias, atopic dermatitis, and food allergy.

In support of improving patient care, Children’s Hospital of Philadelphia is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

AMA PRA Category 1 Credits™ (4.00 hours), ANCC NCPD Contact Hours (4.00 hours), Non-Physician AMA PRA Category 1 Credits™ Attendance (includes PA, RT, RDMS) (4.00 hours)

You are not logged in.

Please click the button below to login or create a new account before continuing.

Mitigation of Relevant Financial Relationships

Children's Hospital of Philadelphia adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Friday, March 20, 2026